Mutant human prourokinase

作者: Yasuo Amatsuji , Masaaki Hirose , Masanori Morita , Toshizumi Tanabe

DOI:

关键词: PlasmidAmino acidMutantFibrinMolecular biologyBiologyBiochemistryFibrinolysinEpidermal growth factor

摘要: A mutant human prourokinase wherein a neutral amino acid in the epidermal growth factor (EGF) region of (human PUK) has been replaced with basic acid, or an acidic non-acidic and method for producing PUK which comprises expression by cultivating host transformed plasmid inserted DNA sequence coding said PUK. By replacing EGF is fibrinolysin half-life blood can be prolonged, affinity fibrin improved.

参考文章(11)
Yasuo Amatsuji, Hirofumi Arimura, Ryuji Hiramatsu, Shunji Kasai, Masanori Nagai, Shusei Uno, Masaaki Hirose, Haruhide Kawabe, Masanori Morita, Toshizumi Tanabe, Human prourokinase mutants ,(1990)
Masaaki C, Shunji C, Yasuo C, Masanori C, Toshizumi C, Haruhide C, Hirofumi C, Human prourokinase variants, methods of producing same, dna sequences, plasmids and hosts therefor ,(1990)
Yasunori Ikeda, Bjorn A. Nexo, Eileen R. Mulvihill, Patrick J. O'hara, Suguru Suzuki, Shinji Yoshitake, Akira Hashimoto, Teruaki Yuzuriha, Tissue plasminogen activator analogs having modified growth factor domains ,(1988)
Tim J. Ahern, Glenn R. Larsen, Novel thrombolytic proteins ,(1987)
Jeffery Hugh Beecham Pharmaceuticals Robinson, Michael Joseph Beecham Pharmaceuticals Browne, Modified fibrinolytic enzyme ,(1987)
L. Guarente, R. R. Yocum, P. Gifford, A GAL10-CYC1 hybrid yeast promoter identifies the GAL4 regulatory region as an upstream site. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 79, pp. 7410- 7414 ,(1982) , 10.1073/PNAS.79.23.7410
Albert Prescott Mathews, Principles of Biochemistry ,(1937)
Francesco Blasi, Giovanni Cassani, Marialuisa Nolli, Federico Maria Robbiati, Modified plasminogen activators ,(1988)
Yasuo Amatsuji, Ken Okabayashi, Hirofumi Arimura, Masanori Nagai, Tadakazu Suyama, Method of producing human prourokinase ,(1987)